Rational design, synthesis, biological evaluation and molecular docking studies of chromone-pyrimidine derivatives as potent anti-cancer agents

Abstract

A new series of pyrimidine based chromone hybrids were synthesized from 7‑methoxy-8-formyl-chromone using facile multi-component modified Biginelli reaction. All the newly synthesized compounds were characterized and evaluated for their in vitro anti-cancer activity against three cancer cell lines, human cervical (HeLa), lung (A549), myelogenous leukaemia (K562) cancer cell lines and on a normal cell line(HEK-293) for the selectivity reference. Among them, compounds 6a, 6b, 6c, 6f, 8a and 8b exhibited potent anti-cancer activities against A549, HeLa and K562 cell lines with IC50 values in micro molar range. The compounds 8a-8e were displayed selective anti-cancer activity against K562 cell line compared to on other cancer cell lines. All the compounds showed relative non-toxicity against normal cell line. The selectivity of the compounds against K562 cell line has been substantiated by molecular docking in BCR-ABL Tyrosine kinase using genetic algorithm program (GOLD 3.0.1). These results indicate that the chromone based derivatives 6a-6j and 8a-8e are promising anti-cancer agents for the effective treatment of different types of cancers.